These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 18566335)
1. Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer. Pedchenko TV; Gonzalez AL; Wang D; DuBois RN; Massion PP Am J Respir Cell Mol Biol; 2008 Dec; 39(6):689-96. PubMed ID: 18566335 [TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta. Han S; Ritzenthaler JD; Wingerd B; Roman J J Biol Chem; 2005 Sep; 280(39):33240-9. PubMed ID: 16061473 [TBL] [Abstract][Full Text] [Related]
3. Effect of ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in human lung cancer cell lines. He P; Borland MG; Zhu B; Sharma AK; Amin S; El-Bayoumy K; Gonzalez FJ; Peters JM Toxicology; 2008 Dec; 254(1-2):112-7. PubMed ID: 18950674 [TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha. Han S; Ritzenthaler JD; Sun X; Zheng Y; Roman J Am J Respir Cell Mol Biol; 2009 Mar; 40(3):325-31. PubMed ID: 18776129 [TBL] [Abstract][Full Text] [Related]
5. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals. Han S; Ritzenthaler JD; Zheng Y; Roman J Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1238-49. PubMed ID: 18390835 [TBL] [Abstract][Full Text] [Related]
6. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. Burdick AD; Bility MT; Girroir EE; Billin AN; Willson TM; Gonzalez FJ; Peters JM Cell Signal; 2007 Jun; 19(6):1163-71. PubMed ID: 17254750 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines. Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664 [TBL] [Abstract][Full Text] [Related]
8. Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Sun X; Ritzenthaler JD; Zhong X; Zheng Y; Roman J; Han S Cancer Res; 2009 Aug; 69(16):6445-53. PubMed ID: 19654299 [TBL] [Abstract][Full Text] [Related]
10. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor. Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940 [TBL] [Abstract][Full Text] [Related]
11. Establishing the Role of PPARβ/δ in Carcinogenesis. Peters JM; Gonzalez FJ; Müller R Trends Endocrinol Metab; 2015 Nov; 26(11):595-607. PubMed ID: 26490384 [TBL] [Abstract][Full Text] [Related]
12. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties. Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691 [TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2. Zhu B; Bai R; Kennett MJ; Kang BH; Gonzalez FJ; Peters JM Mol Cancer Ther; 2010 Dec; 9(12):3267-77. PubMed ID: 21159610 [TBL] [Abstract][Full Text] [Related]
14. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes. Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor beta/delta. Nadra K; Anghel SI; Joye E; Tan NS; Basu-Modak S; Trono D; Wahli W; Desvergne B Mol Cell Biol; 2006 Apr; 26(8):3266-81. PubMed ID: 16581799 [TBL] [Abstract][Full Text] [Related]
16. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line. Foreman JE; Sharma AK; Amin S; Gonzalez FJ; Peters JM Cancer Lett; 2010 Feb; 288(2):219-25. PubMed ID: 19660859 [TBL] [Abstract][Full Text] [Related]
17. Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis. Peters JM; Foreman JE; Gonzalez FJ Cancer Metastasis Rev; 2011 Dec; 30(3-4):619-40. PubMed ID: 22037942 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Girroir EE; Hollingshead HE; Billin AN; Willson TM; Robertson GP; Sharma AK; Amin S; Gonzalez FJ; Peters JM Toxicology; 2008 Jan; 243(1-2):236-43. PubMed ID: 18054822 [TBL] [Abstract][Full Text] [Related]